IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+ patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2) Meeting Abstract
| Authors: | D'Angelo, S. P.; Noujaim, J. C.; Thistlethwaite, F.; Razak, A. R. A.; Stacchiotti, S.; Chow, W. A.; Haanen, J. B. A. G.; Chalmers, A. W.; Robinson, S. I.; Van Tine, B. A.; Ganjoo, K. N.; Johnson, M. L.; Chiou, V. L.; Faitg, T. H.; Woessner, M.; Pearce, L.; Shalabi, A.; Blay, J. Y.; Demetri, G. |
| Abstract Title: | IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+ patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306173 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS11582 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS11582 -- Source: Wos |
